Quick filters
- Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference PR Newswire | Monday May 13, 2013 7:00AM
- Biotechs high on stimulus, not drugs Globe and Mail | Friday May 10, 2013 1:16PM
- Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec PR Newswire | Thursday May 9, 2013 4:34PM
- Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference PR Newswire | Thursday May 9, 2013 2:39PM
- Isis Pharmaceuticals Prices Public Offering Of Common Stock PR Newswire | Wednesday May 8, 2013 9:50PM
- Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock PR Newswire | Tuesday May 7, 2013 4:08PM
- Isis Reports Financial Results and Highlights for First Quarter 2013 PR Newswire | Tuesday May 7, 2013 4:05PM
- Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer PR Newswire | Monday May 6, 2013 7:00AM
- Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call PR Newswire | Thursday May 2, 2013 12:58PM
- ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy PR Newswire | Tuesday April 23, 2013 7:00AM
- Isis Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference PR Newswire | Monday April 22, 2013 5:13PM
- MARKET PULSE-IBM, GE, Interpublic, Manpowergroup, Clayton Williams Globe and Mail | Friday April 19, 2013 9:57AM
- MARKET PULSE-Boeing, McDonald's, Vertex, Kansas City, Isis Globe and Mail | Friday April 19, 2013 9:17AM
- Roche and Isis Pharmaceuticals form alliance for Huntington's disease PR Newswire | Monday April 8, 2013 9:00AM
- Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis PR Newswire | Wednesday April 3, 2013 7:00AM
- Isis Publishes Data Demonstrating Antisense Targeting of ApoC-III Significantly Reduces ApoC-III and Triglycerides PR Newswire | Monday April 1, 2013 7:00AM
- Isis Provides Update on CHMP Opinion on KYNAMRO? (mipomersen) PR Newswire | Friday March 22, 2013 2:30PM
- Data From ISIS-SMN Rx Phase 1 Study in Children With Spinal Muscular Atrophy Presented at the American Academy of Neurology Meeting PR Newswire | Wednesday March 20, 2013 7:13PM
- Isis Pharmaceuticals to Present at the 25th Annual ROTH Conference PR Newswire | Friday March 15, 2013 7:00AM
- Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting PR Newswire | Thursday March 14, 2013 11:00AM
Live Discussion of ISIS on StockTwits